1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Europe miRNA Sequencing and Assay Market – By Product

1.3.2        Europe miRNA Sequencing and Assay Market – By Technology

1.3.3        Europe Global miRNA Sequencing and Assay Market – By End User

1.3.4        Europe miRNA Sequencing and Assay Market – By Country

2.             miRNA Sequencing and Assay Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Europe miRNA Sequencing and Assay – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        Europe – PEST Analysis

4.3       Expert Opinions

5.             miRNA Sequencing and Assay Market – Key Market Dynamics

5.1       Key Market Drivers

5.1.1        Widening Range of MicroRNA Applications

5.1.2        Rise in Funding for Genomics Research

5.2       Market Restraints

5.2.1        Challenges Related to Delivery, Efficacy, and Specificity of miRNA-based Therapeutics

5.3       Market Opportunities

5.3.1        Rising Prevalence of Chronic Conditions and Infectious Diseases

5.4       Future Trends

5.4.1        Development and Launch of Innovative Products

5.5       Impact analysis

6.             miRNA Sequencing and Assay Market – Europe Analysis

6.1       Europe miRNA Sequencing and Assay Market Revenue Forecast and Analysis

7.             miRNA Sequencing and Assay Market Analysis – By Product

7.1       Overview

7.2       miRNA Sequencing and Assay Market Revenue Share, by Product (2019 and 2027)

7.3       Library Preparation

7.3.1        Overview

7.3.2        Library Preparation: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

7.4       Consumables

7.4.1        Overview

7.4.2        Consumables: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

8.             miRNA Sequencing and Assay Market Analysis – By Technology

8.1       Overview

8.2       miRNA Sequencing and Assay Market Share, by Technology, 2019 and 2027, (%)

8.3       Sequencing by Synthesis

8.3.1        Overview

8.3.2        Sequencing by Synthesis: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

8.4       Nanopore

8.4.1        Overview

8.4.2        Nanopore: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

8.5       Ion Semiconductor Sequencing

8.5.1        Overview

8.5.2        Ion Semiconductor Sequencing: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

9.             miRNA Sequencing and Assay Market Analysis – By End User

9.1       Overview

9.2       miRNA Sequencing and Assay Market Share, by End User, 2019 and 2027, (%)

9.3       Research Institute

9.3.1        Overview

9.3.2        Research Institute: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

9.4       Academia

9.4.1        Overview

9.4.2        Academia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

9.5       Contract Research Organizations (CROs)

9.5.1        Overview

9.5.2        Contract Research Organizations (CROs): miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

10.          miRNA Sequencing and Assay Market – Europe Analysis

10.1    Europe: miRNA Sequencing and Assay Market

10.1.1     Overview

10.1.2     Europe: miRNA Sequencing and Assay Market, by Country, 2019 & 2027 (%)

10.1.3     Germany: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.1    Germany: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.2    Germany miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.3.3    Germany miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.3.4    Germany miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.4     UK: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.1    UK: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.2    UK miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.4.3    UK miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.4.4    UK miRNA Sequencing and Assay Market, by End User– Revenue and Forecast to 2027 (USD Million)

10.1.5     France: Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.1    France: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.2    France miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.5.3    France miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.5.4    France miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.6     Spain: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.1    Spain: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.2    Spain miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.6.3    Spain miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.6.4    Spain miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.7     Italy: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1    Italy: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2    Italy miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.7.3    Italy miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.7.4    Italy miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.8     Rest of Europe: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1    Rest of Europe: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2    Rest of Europe miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.8.3    Rest of Europe miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.8.4    Rest of Europe miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.          Impact of COVID-19 Pandemic on Europe miRNA Sequencing and Assay Market

11.1    Europe: Impact Assessment of COVID-19 Pandemic

12.          Industry Landscape

12.1    Overview

12.2    Organic Developments

12.2.1     Overview

12.3    Inorganic Developments

12.3.1     Overview

13.         Company Profiles

13.1    Illumina, Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    THERMO FISHER SCIENTIFIC INC.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    QIAGEN

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    Perkin Elmer, Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    Takara Bio Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    New England Biolabs

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    Norgen Biotek Corp

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    TriLink BioTechnologies Inc.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    Lexogen GmbH

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10 Oxford Nanopore Technologies

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.          Appendix

14.1    About the Insight Partners

14.2    Glossary of Terms

Table 1.             Germany miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 2.             Germany miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 3.             Germany miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 4.             UK miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 5.             UK miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 6.             UK: miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million).

Table 7.             France miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 8.             France miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 9.             France miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 10.          Spain miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 11.          Spain miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 12.          Spain miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13.          Italy miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 14.          Italy miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 15.          Italy miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16.          Rest of Europe miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 17.          Rest of Europe miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 18.          Rest of Europe miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 19.          Organic Developments Done by Companies

Table 20.          Inorganic Developments Done by Companies

Table 21.          Glossary of Terms, miRNA Sequencing and Assay Market

Figure 1.           miRNA Sequencing and Assay Market Segmentation

Figure 2.           miRNA Sequencing and Assay Market Segmentation, By Country

Figure 3.           miRNA Sequencing and Assay Market Overview

Figure 4.           Library Preparation Segment by Product Segment Expected to Witness Rapid Growth

Figure 5.           Europe miRNA Sequencing and Assay Market – Leading Country Markets (US$ Million)

Figure 6.           Europe PEST Analysis

Figure 7.           miRNA Sequencing and Assay Market Impact Analysis of Driver and Restraints

Figure 8.           Europe miRNA Sequencing and Assay Market – Revenue Forecast and Analysis – 2019- 2027

Figure 9.           miRNA Sequencing and Assay Market Revenue Share, by Product (2019 and 2027)

Figure 10.        Library Preparation: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Consumables: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        miRNA Sequencing and Assay Market Share, by Technology, 2019 and 2027 (%)

Figure 13.        Sequencing by Synthesis: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Nanopore: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Ion Semiconductor Sequencing: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        miRNA Sequencing and Assay Market Share, by End User, 2019 and 2027 (%)

Figure 17.        Research Institute: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Academia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Contract Research Organizations (CROs): miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Europe: miRNA Sequencing and Assay Market, by Key Country – Revenue (2019) (USD Million)

Figure 21.        Europe: miRNA Sequencing and Assay Market, by Country, 2019 & 2027 (%)

Figure 22.        Germany: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

Figure 23.        UK: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

Figure 24.        France: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

Figure 25.        Spain: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        Italy: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        Rest of Europe: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        Impact of COVID-19 Pandemic in European Country Markets